A systematic review of synthetic tyrosinase inhibitors and their structure-activity relationship
Z Peng, G Wang, QH Zeng, Y Li, H Liu… - Critical Reviews in …, 2022 - Taylor & Francis
Tyrosinase is a copper-containing oxidation enzyme, which is responsible for the production
of melanin. This enzyme is widely distributed in microorganisms, animals and plants, and …
of melanin. This enzyme is widely distributed in microorganisms, animals and plants, and …
Navigating the synthesis of quinoline hybrid molecules as promising anticancer agents
P Panda, S Chakroborty - ChemistrySelect, 2020 - Wiley Online Library
The emergence of drug resistance and low specificity with side effects are the significant
challenges in pharmaceutical sectors for control of cancer nowadays. Notwithstanding, this …
challenges in pharmaceutical sectors for control of cancer nowadays. Notwithstanding, this …
General α‐amino 1, 3, 4‐oxadiazole synthesis via late‐stage reductive functionalization of tertiary amides and lactams
D Matheau‐Raven, DJ Dixon - … Chemie International Edition, 2021 - Wiley Online Library
An iridium‐catalyzed reductive three‐component coupling reaction for the synthesis of
medicinally relevant α‐amino 1, 3, 4‐oxadiazoles from abundant tertiary amides or lactams …
medicinally relevant α‐amino 1, 3, 4‐oxadiazoles from abundant tertiary amides or lactams …
[HTML][HTML] 1,3,4-Oxadiazole N-Mannich Bases: Synthesis, Antimicrobial, and Anti-Proliferative Activities
The reaction of 5-(3, 4-dimethoxyphenyl)-1, 3, 4-oxadiazole-2 (3 H)-thione 3 with
formaldehyde solution and primary aromatic amines or 1-substituted piperazines, in ethanol …
formaldehyde solution and primary aromatic amines or 1-substituted piperazines, in ethanol …
[HTML][HTML] Green synthetic approach: An efficient eco-friendly tool for synthesis of biologically active oxadiazole derivatives
Green synthetic protocol refers to the development of processes for the sustainable
production of chemicals and materials. For the synthesis of various biologically active …
production of chemicals and materials. For the synthesis of various biologically active …
Design, synthesis, biological evaluation, and molecular docking of some new Thieno [2, 3-d] pyrimidine derivatives
Due to the biological importance of thienopyrimidine derivatives, we present here a synthetic
way for the design of new thienopyrimidines (2‒11) using the precursor 2-(4-Oxo-9-phenyl …
way for the design of new thienopyrimidines (2‒11) using the precursor 2-(4-Oxo-9-phenyl …
Discovery of new 1, 3, 4-oxadiazoles with dual activity targeting the cholinergic pathway as effective anti-Alzheimer agents
Finding an effective anti-Alzheimer agent is quite challenging due to its multifactorial nature.
As such, multitarget directed ligands (MTDLs) could be a promising paradigm for finding …
As such, multitarget directed ligands (MTDLs) could be a promising paradigm for finding …
Structure-based screening for the discovery of 1, 2, 4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid …
M Potenza, M Sciarretta, MG Chini, A Saviano… - European Journal of …, 2021 - Elsevier
The multiple inhibition of biological targets involved in pro-inflammatory eicosanoid
biosynthesis represents an innovative strategy for treating inflammatory disorders in light of …
biosynthesis represents an innovative strategy for treating inflammatory disorders in light of …
[HTML][HTML] Exploring probenecid derived 1, 3, 4-Oxadiazole-phthalimide hybrid as α-amylase inhibitor: Synthesis, structural investigation, and molecular modeling
1, 3, 4-Oxadiazole moiety is a crucial pharmacophore in many biologically active
compounds. In a typical synthesis, probenecid was subjected to a sequence of reactions to …
compounds. In a typical synthesis, probenecid was subjected to a sequence of reactions to …
Discovery of spirooxadiazoline oxindoles with dual-stage antimalarial activity
EA Lopes, R Mestre, D Fontinha, J Legac, JV Pei… - European Journal of …, 2022 - Elsevier
Malaria remains a prevalent infectious disease in developing countries. The first-line
therapeutic options are based on combinations of fast-acting artemisinin derivatives and …
therapeutic options are based on combinations of fast-acting artemisinin derivatives and …